跳至主要内容
临床试验/NCT04623437
NCT04623437已完成不适用

Comprehensive Antineoplastic Therapy Adverse Events Monitoring and Report

University Hospital "Sestre Milosrdnice"1 个研究点 分布在 1 个国家目标入组 267 人开始时间: 2017年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
267
试验地点
1
主要终点
comparison of perspectives

研究概览

简要总结

Study of pharmacovigilance in oncology. Monitoring and management of AEs during antineoplastic treatment.

详细描述

Monitoring and management of AE's during antineoplastic treatment. Comparison of AE's reported by patient with the ones recognised by the oncologist, and vice versa, during antineoplastic treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all cancer patients receiving systemic antineoplastic treatment, ECOG 0-2

排除标准

  • age <18, >75; other active and severe comorbidities; no solid cancer; IUC patients

结局指标

主要结局

comparison of perspectives

时间窗: may 2016 until october 2016

comparison between patient's and oncologist's perspective on severity of AE's during antineoplastic treatment

次要结局

未报告次要终点

研究者

发起方
University Hospital "Sestre Milosrdnice"
申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Šeparović

PhD MD

University Hospital "Sestre Milosrdnice"

研究点 (1)

Loading locations...

相似试验